Organovo Holdings (NASDAQ:ONVO) collaborates with Professor Melissa Little at the Murdoch Children's Research Institute (“MCRI”), The Royal Children’s Hospital, Melbourne, Australia and Ton Rabelink at Universiteit Leiden (“LUMC”), Leiden, Netherlands.
The project will expand the use of 3D bioprinted stem cell-based therapeutic tissues aimed at treating end-stage renal disease.
The collaboration is being funded by Stem Cells Australia and CSL Limited.